Used as a key intermediate in the synthesis of pharmaceutical agents targeting inflammatory and autoimmune diseases. Its structure supports selective modulation of kinase enzymes, particularly involved in signaling pathways related to immune response. Employed in research and development of novel therapeutics for conditions such as rheumatoid arthritis and psoriasis. The compound’s design enables improved binding affinity and metabolic stability, making it valuable in optimizing drug candidates during preclinical studies.